The cladribine trial in secondary progressive MS: response.
Goodin
D S
DS
D015982:Bias; D017338:Cladribine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards*; D003657:Decision Making; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020528:Multiple Sclerosis, Chronic Progressive / Q000145:classification / Q000188:drug therapy*; D012107:Research Design / Q000592:standards*; D012720:Severity of Illness Index
D007166:Immunosuppressive Agents; D017338:Cladribine